Assignee
TRIPLET THERAPEUTICS INC
US·1 granted patent·4 pending applications·2 citations·filing 2019–2021
Top patents by PatentIndex Score
5 records- 0186US11408000B2Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activityTRIPLET THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·2 cites·10 claims
- 0247US2023313185A1Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTRIPLET THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0345US2023041178A1Methods for the treatment of trinucleotide repeat exapnsion disorders associated with ogg1 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0441US2022072028A1Methods for the treatment of trinucleotide repeat expansion disorders associated with msh3 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0541US2022033814A1Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRIPLET THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →